Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

• Päätekijät: Mizrahi M (Tekijä), Shabat Y (Tekijä), Ben Ya'acov A (Tekijä), Lalazar G (Tekijä), Adar T (Tekijä), Wong V (Tekijä), Muller B (Tekijä), Rawlin G (Tekijä), Ilan Y (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Dove Medical Press, 2012-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Meir Mizrahi,1 Yehudit Shabat,1 Ami Ben Ya'acov,1 Gadi Lalazar,1 Tomer Adar,1 Victor Wong,2 Brian Muller,2 Grant Rawlin,2 Yaron Ilan11Liver Unit, Hebrew University-Hadassah Medical Center, Jerusalem, Israel; 2Immuron Limited, North Melbourne, AustraliaBackground: Nonalcoholic steatohepatitis...